Benefits with
SKINVIVE™

Models treated with SKINVIVE™. Individual results may vary.

A hydrated1,* radiance2, that lasts all day, every day for up to 9 months1,2

Delivering up to 270 days of deeply hydrated*,4 skin with just one treatment, SKINVIVE™ is the secret to long-lasting§ hydration.1,*

SKINVIVE™ targets the five signs of healthy-looking skin,2,‖ noticeably improving clarity,2,¶ smoothness,2,** hydration,2,†† radiance2,† So you can restore your skin’s natural radiance2,† without changing your individual look.

The SKINVIVE™
difference

After just one SKINVIVE™ treatment, people
were happy with their skin for up to
9 months.2,‖,§§

AFTER 1 MONTH2,‖

9 in 10

were satisfied with their results2,‖‖

~3 in 4

people were happy with their skin, even when they first woke up2,¶¶

3x more

3x people were happy with how radiant*** their skin looked (than before treatment)2

AFTER 9 MONTHS...2,‖

3 in 4

were happy with how healthy††† their skin looked2

Nearly

9 in 10

would recommend SKINVIVE™ to a friend2

Discover why real SKINVIVE™ patients love their results

See the SKINVIVE™ difference
up close

Discover high-definition Before & After photos of real patients and see transformative skin hydration results with SKINVIVE™.

Individual results may vary.

Find your nearest clinic

For a deep, long-lasting§
injectable skin hydration treatment that
helps you meet your unique beauty
goals,1,3 speak to a practitioner about
SKINVIVE™.

Invalid postcode. Please try again.

SKINVIVE™ by JUVÉDERM® is an injectable implant used for the treatment, by filling, of superficial cutaneous depressions such as fine lines and for additional improvement of skin quality attributes such as hydration and elasticity.3

Footnotes

  • *Instrument measures of skin hydration, smoothness, and skin deformation parameters were performed on the cheek, forehead, and neck of one side of the face on Day 0 and at 30 days after initial treatment (before touch up), Months 1, 4, 6, and 9 after the last treatment, and Month 1R. Skin hydration was measured using the MoistureMeterD instrument (n=131) and top-up treatment administered at Day 30 (n=31).1
  • Lasting up to 9 months as reported by 63% of patients. As reported by 127 of 131 patients in a composite satisfaction score, which includes how radiant their facial skin looked.2
  • Skin hydration was measured using the MoistureMeterD instrument with the XS 5 and S 15 probes (depth of effective measurement: 0.5 and 1.5 mm, respectively).1
  • §Long-lasting is up to 9 months following a single treatment.1
  • Subjects completed the FACE-Q Satisfaction With Skin scale at baseline (Day 0, before treatment), Months 1, 4, 6, and 9 (before repeat treatment, if received), and Month 1 after the repeat treatment (n=131; n=62 received repeat treatment). The Satisfaction With Skin scale is a validated patient-reported outcome instrument designed to assess the impact of treatment from the subject’s perspective. The scale comprises 12 questions about satisfaction with different facial skin attributes (e.g. smoothness, clearness, radiance). Responses are rated on a 4-point scale (1: very dissatisfied, 4: very satisfied). Scores for each item were summed and converted to a scale score (range: 0–100; higher scores indicate greater satisfaction) using the algorithm developed by the FACE-Q developers.2
  • Lasting up to 9 months as reported by 64.6% of patients. As reported by 127 of 131 patients in a composite satisfaction score, which includes how clear their facial skin looked.2
  • **Lasting up to 9 months as reported by 55.1% of patients. As reported by 127 of 131 patients in a composite satisfaction score, which includes how smooth their facial skin looked.2
  • ††Lasting up to 9 months as reported by 70.6% of patients. As reported by 127 of 131 patients (1 subject did not respond) in a composite satisfaction score, which includes how hydrated their facial skin looked.2
  • ‡‡Lasting up to 9 months as reported by 67.7% of patients. As reported by 127 of 131 patients (3 subjects did not respond) in a composite satisfaction score, which includes satisfaction with their skin’s tone (colour).2
  • §§Defined as having improved satisfaction from baseline on the FACE-Q Satisfaction With Skin scale, as reported by 127 of 131 patients at Month 9.2
  • ‖‖Defined as having improved satisfaction from baseline on the FACE-Q Satisfaction With Skin scale, as reported by 131 patients at Month 1.2
  • ¶¶At Month 1, 74.0% and 73.3% of 131 patients were somewhat satisfied or very satisfied with their skin at first wake-up and end of day, respectively.2
  • ***At Month 1, 82.4% of 131 patients were somewhat satisfied or very satisfied with how radiant their facial skin looked.2
  • †††Lasting up to 9 months as reported by 76.2% of patients. As reported by 127 of 131 patients (1 subject did not respond) in a composite satisfaction score, which includes how healthy their skin looked.2

References

  1. Niforos F et al. Clin Cosmet Investig Dermatol. 2019;12:791-798.
  2. Ogilvie P et al. J Cosmet Dermatol. 2020;19(5):1065-1070.
  3. SKINVIVE™ by Juvéderm® Direction for Use.
  4. Nakab L et al. Plast Reconstr Surg Glob Open. 2020;8(3):e2723.

Models treated with SKINVIVE™. Individual results may vary.

Website produced and funded by Allergan Aesthetics, an AbbVie company.

Directions for consumers

This content is intended for India adult (>18yrs) audience only. You should always consult a healthcare professional to help you decide if SKINVIVE™ by JUVÉDERM® is right for you and provide you with a full list of side effects.

Directions for healthcare professionals

Patients may experience potential side effects with SKINVIVE™ by JUVÉDERM®, which include inflammatory reactions (redness, oedema, erythema, etc.), haematomas, induration or nodules, staining or discolourations at injection site, etc. Please refer to SKINVIVE™ by JUVÉDERM® Directions for Use (DFU) for a full list of adverse events.4

Adverse events should be reported.
Adverse events should also be reported to Allergan Aesthetics at MedDeviceComplaintsAPAC@Abbvie.com